Month: August 2020

En ekstraordinær generalforsamling i Aqua Bio Technology ASA (“ABT” og “Selskapet“) skal avholdes den 11. september 2020 kl. 10.00 hos Advokatfirmaet CLP DA, Sommerrogata 13-15, 0255 Oslo.Vedlagt følger innkallingen til den ekstraordinære generalforsamlingen sammen med påmeldings- og fullmaktsskjema.Som følge av koronasituasjonen, anmoder Selskapet aksjonærene om å avstå fra å møte fysisk på generalforsamlingen og heller stemme gjennom fullmakt.Aksjonærer som ønsker å delta på generalforsamlingen oppfordres til å gi melding til Selskapet om dette slik angitt i innkallingen innen den 10. september 2020 kl. 16:00. Ved bruk av fullmakt anmodes fullmaktsskjemaet sendt slik at det mottas av Selskapet innen samme dato.Denne opplysningen er informasjonspliktig etter verdipapirhandelloven § 5-12. Vedlegg200820 Aqua Bio...

MCLEAN, Va., Aug. 20, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) closed its third Multifamily Credit Insurance Pool (“MCIP”) offering, MCIP 2020-R3. The transaction reinsures risk on a $2.6 billion reference pool made up of 136 multifamily loans.Partnering with reinsurance broker Aon, Freddie Mac retains the first 1.00% of losses, and has purchased credit risk insurance for the next 5.5% of credit losses on the reference pool which consists of conventional and affordable loans in Freddie Mac’s Multifamily Participation Certificate program.In MCIP transactions, Freddie Mac enters into long-term credit insurance contracts whereby a portion of any credit losses that occurs from existing multifamily loans in the company’s portfolio or bonds that Freddie Mac fully guarantees is covered by reinsurers. By transferring a percentage...

HUNTINGTON BEACH, CA, Aug. 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — J. Craig Holding Corp., fka Ultra Pure Water Technologies, Inc. (OTC: UPWT), an accelerator and incubator for innovative businesses, intellectual properties and assets, has submitted the application to FINRA in order to officially change the company name and receive a ticker symbol that will better reflect the company’s current business strategy.Caren Currier, CFO, stated, “I personally prepared and submitted the Firm Name Reservation Request and anticipate a response within a couple of weeks. This is an important piece of J. Craig Holding Corp’s transition process from the old business of Ultra Pure Water Technologies.”About J. Craig Holding Corp. (OTC: UPWT)Investor Relations ContactDana SalzaruloDirector Investor RelationsInfo@jcholdingcorp.com 1-833-333-5242...

TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has entered into additional agreement for providing IT solution and services totalling approximately $250,000 with two divisions of LOTTE companies (“LOTTE”), LOTTE Home Shopping and LOTTE Property and Development.LOTTE Home Shopping aims to provide a creative consumer experience by working with customers to build trust and satisfy their needs. It operates businesses in the areas of television shopping, Internet shopping malls, catalogues, and mobile shopping in South Korea and internationally, including locations in Japan, South Korea, China, Indonesia, and Vietnam.LOTTE Property & Development operates as a high rise multi-purpose...

Company Announcement Kesimpta® (ofatumumab) approved by U.S. FDA for the treatment of relapsing forms of multiple sclerosis in adultsFirst B-cell therapy that can be self-administered using Sensoready® autoinjector penApproval based on Phase III ASCLEPIOS I and II studiesCopenhagen, Denmark; August 20, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (U.S. FDA) has approved the use of Kesimpta® (ofatumumab) injection for subcutaneous use, for the treatment of relapsing forms of multiple sclerosis (RMS) in adults, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Kesimpta is the first B-cell therapy that can be self-administered by patients at home using the Sensoready® autoinjector pen, once monthly after starting therapy. It is being...

Kesimpta delivers powerful efficacy with a favorable safety profile and can be self-administered at home, addressing significant unmet needs for people living with relapsing forms of multiple sclerosis (RMS)1 Approval based on two Phase III ASCLEPIOS studies demonstrating significant reductions in risk of relapses, confirmed disability progression, Gd+ T1 brain lesions and new/enlarging T2 lesions1 Kesimpta may halt new disease activity in RMS patients as shown in a post hoc analysis, with 47.0% and 87.8% of patients treated with ofatumumab achieving no evidence of disease activity (NEDA-3) within the first (0–12 months) and second year (12–24 months) of treatment, respectively2The digital press release with multimedia content can be accessed here:Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration...

WOBURN, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a leader in cloud-based digital experience software, announced today that a major US drop shipping supplier has selected Celebros Search by Bridgeline to enhance the site search capabilities of its online store and improve their customer experience.The Company provides a platform for resellers to access more than 20,000 organic, specialty, and gourmet products online. Major eCommerce platforms such as WooCommerce and Shopify can import products from their website to be delivered directly to consumers. These products are shipped from the Company’s facilities in Los Angeles, Pennsylvania, and Dallas Fort-Worth.The Company found Celebros through Magento, an eCommerce provider and longtime partner to Bridgeline. After a demo of Celebros, the Company...

NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS Biotec for the sale and distribution of its proprietary IV-Cell cytogenetics cell culturing media. The companies recently completed the development and have fully validated new version of its media, a next-generation improved product that will yield increased benefits over its first version. Both companies have developed an ambitious go-to-market strategy that will be launched next month, and will be joining forces to rapidly bring the product to market, introducing it to the top major labs worldwide.ADS, and its Japanese parent company ADSTEC, are a worldwide market leader in developing, manufacturing and distributing the HANABI™ cytogenetics...

LEESBURG, Va., Aug. 20, 2020 (GLOBE NEWSWIRE) — Quantum Computing Inc. (OTCQB: QUBT) (QCI), a technology leader in quantum-ready applications and tools, and only public pure play in the quantum computer space, now offers simplified access to several of the world’s top quantum computers (QCs) with its industry-leading Mukai™ software development and execution platform.QCI is the first company with a quantum software development and execution platform to provide the widest selection of QCs via the cloud, including those offered by IonQ, D-Wave, IBM, Rigetti, and others.The same high-level constrained-optimization interface Mukai provides for running applications using its state-of-the-art classical solver can now be used to solve problems on a range of quantum computers, but without any program changes or setting up individual accounts...

Leverkusen, Germany, Aug. 20, 2020 (GLOBE NEWSWIRE) — On August 18, 2020, Biofrontera AG (shares of Biofrontera AG ISIN: DE 00 6046113) announced the successful placement of the 1.00% qualified subordinated mandatory convertible bond 2020/2021 with gross proceeds of EUR 7.9 million. Within the scope of the issuance, 2,638,150 qualified subordinated mandatory convertible bearer bonds (the “Bond”) were issued. The subscription price equaled 100% of the nominal value, corresponding to EUR 3.00 per Bond.The mandatory convertible bond 2020/2021, with the German Securities Identification Number A3E454 / ISIN DE000A3E4548, matures on December 20, 2021 and has been admitted for trading on the Open Market of the Frankfurt Stock Exchange as of today, August 20, 2020.According to Section 8 (2) of the terms and conditions of the...